VONVENDI is indicated for adults
with VWD for:
VONVENDI is unique
A shield with a plus sign in the middle icon.

VONVENDI is the first and only treatment that has been studied and approved for routine prophylaxis in adults with severe Type 3 VWD receiving on-demand therapy1

A stopwatch with a side missing icon.

VONVENDI has a uniquely long half-life (22.6 hours [50 IU/kg])1

Ultra-large multimers found in plasma icon.

VONVENDI contains ultra-large multimers as well as all other
multimers found in plasma**1

**There are no data to indicate that VONVENDI efficacy is enhanced due to its
multimeric composition or its mechanism of action

Discover all the ways VONVENDI is unique